Search

Akm E. Ullah

Examiner (ID: 10221, Phone: (571)272-2361 , Office: P/2874 )

Most Active Art Unit
2874
Art Unit(s)
2874, 2606, 2501, 1734, 2899, 3621, 2838
Total Applications
3400
Issued Applications
3065
Pending Applications
95
Abandoned Applications
245

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 12240139 [patent_doc_number] => 20180073002 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-03-15 [patent_title] => 'ACTIVATABLE CRISPR/CAS9 FOR SPATIAL AND TEMPORAL CONTROL OF GENOME EDITING' [patent_app_type] => utility [patent_app_number] => 15/559898 [patent_app_country] => US [patent_app_date] => 2016-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 25668 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15559898 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/559898
Activatable CRISPR/CAS9 for spatial and temporal control of genome editing Apr 7, 2016 Issued
Array ( [id] => 12607239 [patent_doc_number] => 20180094243 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-04-05 [patent_title] => COMPOSITION AND METHODS OF GENOME EDITING OF B-CELLS [patent_app_type] => utility [patent_app_number] => 15/564070 [patent_app_country] => US [patent_app_date] => 2016-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19357 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15564070 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/564070
COMPOSITION AND METHODS OF GENOME EDITING OF B-CELLS Apr 3, 2016 Abandoned
Array ( [id] => 12733084 [patent_doc_number] => 20180136195 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-05-17 [patent_title] => METHOD FOR SCREENING FOR CANCER THERAPEUTIC AGENT [patent_app_type] => utility [patent_app_number] => 15/563987 [patent_app_country] => US [patent_app_date] => 2016-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9909 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15563987 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/563987
Method for screening for cancer therapeutic agent Mar 31, 2016 Issued
Array ( [id] => 12233391 [patent_doc_number] => 20180066253 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-03-08 [patent_title] => 'METHODS AND COMPOSITIONS FOR MODIFYING ENDOTHELIAL CELLS' [patent_app_type] => utility [patent_app_number] => 15/560007 [patent_app_country] => US [patent_app_date] => 2016-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 24829 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15560007 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/560007
METHODS AND COMPOSITIONS FOR MODIFYING ENDOTHELIAL CELLS Mar 21, 2016 Abandoned
Array ( [id] => 12260589 [patent_doc_number] => 20180079786 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-03-22 [patent_title] => 'CONSTRUCTS FOR CONTINUOUS MONITORING OF LIVE CELLS' [patent_app_type] => utility [patent_app_number] => 15/558497 [patent_app_country] => US [patent_app_date] => 2016-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 7443 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15558497 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/558497
Constructs for continuous monitoring of live cells Mar 15, 2016 Issued
Array ( [id] => 11567401 [patent_doc_number] => 20170106046 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-04-20 [patent_title] => 'METHOD FOR DIAGNOSING AND TREATING CANCER USING NAIVE STATE STEM CELL SPECIFIC GENES' [patent_app_type] => utility [patent_app_number] => 15/060484 [patent_app_country] => US [patent_app_date] => 2016-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 82 [patent_figures_cnt] => 82 [patent_no_of_words] => 10650 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15060484 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/060484
METHOD FOR DIAGNOSING AND TREATING CANCER USING NAIVE STATE STEM CELL SPECIFIC GENES Mar 2, 2016 Abandoned
Array ( [id] => 10981671 [patent_doc_number] => 20160178615 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-06-23 [patent_title] => 'RGD-BINDING COMPOUNDS AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 15/056522 [patent_app_country] => US [patent_app_date] => 2016-02-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 6555 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15056522 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/056522
RGD-BINDING COMPOUNDS AND METHODS OF USE Feb 28, 2016 Abandoned
Array ( [id] => 11040451 [patent_doc_number] => 20160237407 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-08-18 [patent_title] => 'UNIVERSAL DONOR CHIMERIC ANTIGEN RECEPTOR CELLS' [patent_app_type] => utility [patent_app_number] => 15/046259 [patent_app_country] => US [patent_app_date] => 2016-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6923 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15046259 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/046259
UNIVERSAL DONOR CHIMERIC ANTIGEN RECEPTOR CELLS Feb 16, 2016 Abandoned
Array ( [id] => 12151517 [patent_doc_number] => 20180022781 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-01-25 [patent_title] => 'POLYPEPTIDES FOR ENGINEERING INTEGRASE CHIMERIC PROTEINS AND THEIR USE IN GENE THERAPY' [patent_app_type] => utility [patent_app_number] => 15/549531 [patent_app_country] => US [patent_app_date] => 2016-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 15299 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15549531 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/549531
POLYPEPTIDES FOR ENGINEERING INTEGRASE CHIMERIC PROTEINS AND THEIR USE IN GENE THERAPY Feb 11, 2016 Abandoned
Array ( [id] => 10814138 [patent_doc_number] => 20160160298 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-06-09 [patent_title] => 'DIAGNOSTIC METHODS FOR DETERMINING PROGNOSIS OF NON-SMALL CELL LUNG CANCER' [patent_app_type] => utility [patent_app_number] => 15/019689 [patent_app_country] => US [patent_app_date] => 2016-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 9928 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15019689 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/019689
DIAGNOSTIC METHODS FOR DETERMINING PROGNOSIS OF NON-SMALL CELL LUNG CANCER Feb 8, 2016 Abandoned
Array ( [id] => 12151815 [patent_doc_number] => 20180023079 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-01-25 [patent_title] => 'Circular RNA For The Diagnosis Of Cardiovascular And Inflammatory Diseases' [patent_app_type] => utility [patent_app_number] => 15/548325 [patent_app_country] => US [patent_app_date] => 2016-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 13211 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15548325 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/548325
Circular RNA For The Diagnosis Of Cardiovascular And Inflammatory Diseases Feb 2, 2016 Abandoned
Array ( [id] => 12227705 [patent_doc_number] => 09914940 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-03-13 [patent_title] => 'Targeted integration into the PPP1R12C locus' [patent_app_type] => utility [patent_app_number] => 15/014372 [patent_app_country] => US [patent_app_date] => 2016-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 21 [patent_no_of_words] => 20104 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15014372 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/014372
Targeted integration into the PPP1R12C locus Feb 2, 2016 Issued
Array ( [id] => 13690019 [patent_doc_number] => 20170355964 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-12-14 [patent_title] => Delta133P53Beta and Delta133P53Gamma Isoforms Are Biomarkers of Cancer Stem Cells [patent_app_type] => utility [patent_app_number] => 15/547211 [patent_app_country] => US [patent_app_date] => 2016-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22945 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15547211 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/547211
Delta133p53beta and delta133p53gamma isoforms are biomarkers of cancer stem cells Jan 31, 2016 Issued
Array ( [id] => 15753717 [patent_doc_number] => 10618954 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-04-14 [patent_title] => CKAP4-molecular-targeted antitumor agent [patent_app_type] => utility [patent_app_number] => 15/553941 [patent_app_country] => US [patent_app_date] => 2016-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 18694 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15553941 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/553941
CKAP4-molecular-targeted antitumor agent Jan 27, 2016 Issued
Array ( [id] => 15423031 [patent_doc_number] => 10544431 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-01-28 [patent_title] => Gene expression system using stealthy RNA, and gene introduction/expression vector including said RNA [patent_app_type] => utility [patent_app_number] => 15/544084 [patent_app_country] => US [patent_app_date] => 2016-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 27 [patent_no_of_words] => 29949 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 355 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15544084 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/544084
Gene expression system using stealthy RNA, and gene introduction/expression vector including said RNA Jan 17, 2016 Issued
Array ( [id] => 10980451 [patent_doc_number] => 20160177395 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-06-23 [patent_title] => 'BIOMARKERS FOR THE PREDICTION OF RENAL INJURY' [patent_app_type] => utility [patent_app_number] => 14/990762 [patent_app_country] => US [patent_app_date] => 2016-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 50689 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14990762 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/990762
BIOMARKERS FOR THE PREDICTION OF RENAL INJURY Jan 6, 2016 Abandoned
Array ( [id] => 13722093 [patent_doc_number] => 20170372001 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-12-28 [patent_title] => MODELING RIBOSOME DYNAMICS TO OPTIMIZE HETEROLOGOUS PROTEIN PRODUCTION [patent_app_type] => utility [patent_app_number] => 15/541941 [patent_app_country] => US [patent_app_date] => 2016-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34201 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15541941 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/541941
MODELING RIBOSOME DYNAMICS TO OPTIMIZE HETEROLOGOUS PROTEIN PRODUCTION Jan 5, 2016 Abandoned
Array ( [id] => 16942194 [patent_doc_number] => 11054424 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-07-06 [patent_title] => Cell identification method [patent_app_type] => utility [patent_app_number] => 15/538742 [patent_app_country] => US [patent_app_date] => 2015-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 21 [patent_no_of_words] => 14361 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 425 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15538742 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/538742
Cell identification method Dec 16, 2015 Issued
Array ( [id] => 10814062 [patent_doc_number] => 20160160222 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-06-09 [patent_title] => 'DNA MOLECULES AND METHODS' [patent_app_type] => utility [patent_app_number] => 14/960136 [patent_app_country] => US [patent_app_date] => 2015-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 20851 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14960136 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/960136
DNA molecules and methods Dec 3, 2015 Issued
Array ( [id] => 10978397 [patent_doc_number] => 20160175339 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-06-23 [patent_title] => 'METHODS FOR DETECTING AND MODULATING THE SENSITIVITY OF TUMOR CELLS TO ANTI-MITOTIC AGENTS AND FOR MODULATING TUMORIGENICITY' [patent_app_type] => utility [patent_app_number] => 14/951992 [patent_app_country] => US [patent_app_date] => 2015-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 31526 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14951992 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/951992
METHODS FOR DETECTING AND MODULATING THE SENSITIVITY OF TUMOR CELLS TO ANTI-MITOTIC AGENTS AND FOR MODULATING TUMORIGENICITY Nov 24, 2015 Abandoned
Menu